Biliary excretion of moxalactam
Open Access
- 1 August 1981
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 20 (2) , 231-234
- https://doi.org/10.1128/aac.20.2.231
Abstract
The biliary excretion of moxalactam was studied in 11 postsurgery patients who had indwelling T-tubes inserted in their common bile ducts. Peak levels of moxalactam in the bile reached mean levels of 33.7 +/- 11.1 and 173.7 +/- 67.0 micrograms/ml 2 h after intravenous administration of a single 500- or 2,000-mg dose, respectively. In 5 of the 10 patients given the 2,000-mg dose, peak moxalactam concentrations in the bile were 2 to 12 times higher than simultaneous serum levels, but considerable variation in the biliary excretion of moxalactam was observed among the individual patients.This publication has 17 references indexed in Scilit:
- Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteriaAntimicrobial Agents and Chemotherapy, 1980
- In Vitro Activity of LY127935Antimicrobial Agents and Chemotherapy, 1979
- LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activityAntimicrobial Agents and Chemotherapy, 1979
- Biliary levels of cefoxitinJournal of Antimicrobial Chemotherapy, 1979
- Bacterial Isolates in Cholecystitis and CholelithiasisScandinavian Journal of Gastroenterology, 1979
- Excretion of Cefamandole, Cefazolin, and Cephalothin into T-Tube BileAntimicrobial Agents and Chemotherapy, 1978
- Prophylactic use of cephazolin against wound sepsis after cholecystectomy.BMJ, 1977
- Bacteria and biliary tract diseaseThe American Journal of Surgery, 1974
- Biliary Tract Excretion of Cefazolin, Cephalothin, and Cephaloridine in the Presence of Biliary Tract DiseaseAntimicrobial Agents and Chemotherapy, 1974
- Cephalexin Levels in Human Bile in Presence of Biliary Tract DiseaseBMJ, 1972